Home › Funds › Boxer Capital Management, LLC › RLAY
Boxer Capital Management, LLC position in RLAY
RELAY THERAPEUTICS INC COM · Health Care
Boxer Capital Management, LLC reported holding 450,000 shares of RLAY (RELAY THERAPEUTICS INC COM) in its Q2 2026 13F filing — a position valued at US$8.4M, representing 0.63% of its reported portfolio and ranking #30 among its reported holdings. Boxer Capital Management, LLC has disclosed RLAY holdings in 2 of the last 7 reported quarters, going back to Q4 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Boxer Capital Management, LLC's RLAY position evolved
Boxer Capital Management, LLC first disclosed a stake in RLAY in Q4 2024 at 536,132 shares (US$2.2M). The position peaked in Q2 2026 at 450,000 shares, worth US$8.4M. Across 2 filings, Boxer Capital Management, LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 450,000 shares valued at US$8.4M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 536.13K | $2.21M | New |
| Q2 2026 | 450.00K | $8.42M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About RLAY and 13F data
RLAY (RELAY THERAPEUTICS INC COM) is a Health Care company. 65 other funds we track also report a position in RLAY — the largest reported positions include SB INVESTMENT ADVISERS (UK) LTD (US$522.1M), Casdin Capital (US$300.0M), PERCEPTIVE ADVISORS LLC (US$263.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding RLAY
- SB INVESTMENT ADVISERS (UK) LTD 27.90M sh · $522.10M · Q2 2026
- Casdin Capital 16.04M sh · $300.02M · Q2 2026
- PERCEPTIVE ADVISORS LLC 14.11M sh · $263.93M · Q2 2026
- Commodore Capital LP 12.00M sh · $224.52M · Q2 2026
- Nextech Invest Ltd. 6.78M sh · $126.79M · Q2 2026
- Bellevue Group AG 6.19M sh · $115.74M · Q2 2026
- TCG Crossover Management, LLC 4.27M sh · $79.95M · Q2 2026
- Siren, L.L.C. 3.65M sh · $68.29M · Q2 2026
- Kynam Capital Management, LP 3.30M sh · $61.74M · Q2 2026
- Spruce Street Capital LP 2.98M sh · $55.83M · Q2 2026
- BAKER BROS. ADVISORS LP 2.83M sh · $52.89M · Q2 2026
- MPM BioImpact LLC 2.42M sh · $45.20M · Q2 2026
More on Boxer Capital Management, LLC
FAQ
How long has Boxer Capital Management, LLC held RLAY?
Boxer Capital Management, LLC has disclosed RLAY holdings in 2 of the last 7 reported quarters, going back to Q4 2024.
What is Boxer Capital Management, LLC's current position in RLAY?
As of Q2 2026, Boxer Capital Management, LLC holds 450.00K shares of RLAY (RELAY THERAPEUTICS INC COM), valued at $8.42M, representing 0.63% of its reported portfolio and ranking #30.
Has Boxer Capital Management, LLC been buying or selling RLAY?
In the latest 13F filing (Q2 2026), Boxer Capital Management, LLC newly opened its position in RLAY. The position peaked in Q2 2026 at 450.00K shares.
Which other funds hold RLAY?
Other major institutional holders of RLAY include SB INVESTMENT ADVISERS (UK) LTD, Casdin Capital, PERCEPTIVE ADVISORS LLC, among 65 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.